Revelation Biosciences Ownership
| REVB Stock | USD 2.84 0.07 2.41% |
Revelation |
Revelation Stock Ownership Analysis
The company has price-to-book ratio of 0.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Revelation Biosciences recorded a loss per share of 87.68. The entity had not issued any dividends in recent years. The firm had 1:16 split on the 28th of January 2025. Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company was founded in 2020 and is based in San Diego, California. Revelation Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. To find out more about Revelation Biosciences contact James Rolke at 650 800 3717 or learn more at https://www.revbiosciences.com.Besides selling stocks to institutional investors, Revelation Biosciences also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Revelation Biosciences' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Revelation Biosciences' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Revelation Biosciences Quarterly Liabilities And Stockholders Equity |
|
Revelation Biosciences Insider Trades History
About 5.0% of Revelation Biosciences are currently held by insiders. Unlike Revelation Biosciences' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Revelation Biosciences' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Revelation Biosciences' insider trades
Revelation Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Revelation Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Revelation Biosciences backward and forwards among themselves. Revelation Biosciences' institutional investor refers to the entity that pools money to purchase Revelation Biosciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Xtx Topco Ltd | 2024-12-31 | 49.8 K | Ubs Group Ag | 2024-12-31 | 0.0 | Two Sigma Securities, Llc | 2024-12-31 | 29.1 K | Tower Research Capital Llc | 2024-12-31 | 2.5 K | Sbi Securities Co Ltd | 2024-12-31 | 301 | Royal Bank Of Canada | 2024-12-31 | 100.0 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 6.0 | Susquehanna International Group, Llp | 2024-12-31 | 0.0 | Pom Investment Strategies, Llc | 2024-12-31 | 0.0 | Sabby Management Llc | 2024-12-31 | 0.0 | Bank Of America Corp | 2024-12-31 | 0.0 |
Revelation Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Revelation Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Revelation Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Revelation Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Revelation Biosciences' latest congressional trading
Congressional trading in companies like Revelation Biosciences, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Revelation Biosciences by those in governmental positions are based on the same information available to the general public.
| 2019-08-06 | Senator Pat Toomey | Acquired $15K to $50K | Verify | ||
| 2018-08-03 | Senator Pat Toomey | Acquired $15K to $50K | Verify | ||
| 2018-07-18 | Senator Pat Toomey | Acquired $15K to $50K | Verify | ||
| 2018-05-15 | Senator Pat Toomey | Acquired Under $15K | Verify | ||
| 2018-05-01 | Senator Pat Toomey | Acquired Under $15K | Verify | ||
| 2018-04-10 | Senator Pat Toomey | Acquired Under $15K | Verify | ||
| 2018-03-07 | Senator Pat Toomey | Acquired Under $15K | Verify | ||
| 2018-02-07 | Senator Pat Toomey | Acquired Under $15K | Verify | ||
| 2018-01-10 | Senator Pat Toomey | Acquired Under $15K | Verify | ||
| 2017-12-21 | Senator Pat Toomey | Acquired Under $15K | Verify |
Revelation Biosciences Outstanding Bonds
Revelation Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Revelation Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Revelation bonds can be classified according to their maturity, which is the date when Revelation Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| US761330AB54 Corp BondUS761330AB54 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| RETAIL PPTYS AMER Corp BondUS76131VAA17 | View | |
| US76131VAB99 Corp BondUS76131VAB99 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Revelation Biosciences Corporate Filings
8K | 17th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 6th of March 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F4 | 13th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 13th of January 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. If investors know Revelation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revelation Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Revelation Biosciences is measured differently than its book value, which is the value of Revelation that is recorded on the company's balance sheet. Investors also form their own opinion of Revelation Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Revelation Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revelation Biosciences' market value can be influenced by many factors that don't directly affect Revelation Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revelation Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revelation Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revelation Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.